Independent
Tenure on this board
5.1 yrs
Also a director at
Alexandria Real Estate Equities Inc (ARE)Exelixis Inc (EXEL)
Meeting calendar
BIIB · Annual meeting · Tuesday, June 9, 2026
Biogen Inc
10 nominees · 3 ballot items.
Elect 10 directors; ratify PwC as independent auditor; advisory vote on executive compensation.
Market cap
$30.4B
1Y TSR
+56.8%
Board grade
C-
Record date
Apr 21, 2026
Filing
DEF 14A
Meeting concluded · Jun 9, 2026
Follow how the vote landed and what changed on Biogen Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
Proposals
On the ballot3
- 1
Election of Directors
ManagementBoard: FORElect the 10 nominees listed to the Board for one-year terms.
- 2
Ratification of the Selection of Our Independent Registered Public Accounting Firm
ManagementBoard: FORRatify PricewaterhouseCoopers LLP as Biogen’s independent registered public accounting firm for fiscal year 2026.
More detail
Proposal asks stockholders to ratify PwC as independent auditor for 2026. Management seeks approval as good governance practice though not required; Audit Committee oversees auditor selection and periodic rotation of lead partners, believes PwC independence and experience supports continued retention; ratification provides shareholder input but committee can change engagement regardless of vote.
- 3
Advisory Vote on Executive Compensation (Say on Pay
ManagementBoard: FORNon-binding advisory vote to approve the compensation of named executive officers as disclosed in the proxy statement.
More detail
Non-binding advisory vote asking stockholders to approve NEO compensation. Management argues programs are performance-based, with STI and LTI structures, stockholder engagement informed changes for 2026, and CMDC will consider vote outcome in future decisions; proposal is routine, non-binding, and abstentions count as against.
Director elections
Nominees on the ballot10
Independent
Tenure on this board
7.1 yrs
Also a director at
Mimedx Group Inc (MDXG)Bioventus Inc (BVS)
Independent
Tenure on this board
3.1 yrs
Independent
Tenure on this board
7.1 yrs
Also a director at
International Flavors & Fragrances Inc (IFF)
Independent
Tenure on this board
1.8 yrs
Also a director at
Caris Life Sciences Inc (CAI)
Independent
Tenure on this board
1.5 yrs
Also a director at
Absci Corp (ABSI)
Independent
Tenure on this board
2.5 yrs
Independent
Tenure on this board
16.3 yrs
Independent
Tenure on this board
16.3 yrs
Also a director at
Neurocrine Biosciences Inc (NBIX)
Not independent
Tenure on this board
3.7 yrs
Ownership
Latest 13F quarterTop institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | PRIMECAP MANAGEMENT CO/CA/ | 10.0% | 14,757,607 | $2.7B |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 6.5% | 9,537,417 | $1.7B |
| 3 | FMR LLC | 5.6% | 8,285,749 | $1.5B |
| 4 | STATE STREET CORP | 4.9% | 7,167,922 | $1.3B |
| 5 | VANGUARD PORTFOLIO MANAGEMENT LLC | 4.4% | 6,531,727 | $1.2B |
| 6 | BlackRock, Inc. | 3.9% | 5,828,187 | $1.1B |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 2.6% | 3,871,293 | $707M |
| 8 | BlackRock, Inc. | 2.1% | 3,146,675 | $577M |
| 9 | WELLINGTON MANAGEMENT GROUP LLP | 1.9% | 2,860,725 | $524M |
| 10 | AQR CAPITAL MANAGEMENT LLC | 1.3% | 1,873,057 | $337M |
Peers
Nearest market capOther Healthcare sector meetings6
Upcoming shareholder meetings at Biogen Inc’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Steris PLCSTE
Annual meeting·Jul 31, 2026·$21.6B
Jazz Pharmaceuticals PLCJAZZ
Annual meeting·Jul 23, 2026·$15.2B
Apogee Therapeutics IncAPGE
Special meeting·Aug 11, 2026·$10.1B
Amneal Pharmaceuticals IncAMRX
Special meeting·Jul 31, 2026·$5.8B
Doximity IncDOCS
Annual meeting·Aug 27, 2026·$4.1B
Haemonetics CorpHAE
Annual meeting·Jul 24, 2026·$3.6B
Reference
Frequently asked questions
- When is the Biogen Inc 2026 annual meeting?
- Biogen Inc (BIIB) holds its 2026 annual shareholder meeting on Tuesday, June 9, 2026.
- What is the record date for the Biogen Inc 2026 meeting?
- The record date for the Biogen Inc 2026 meeting is Tuesday, April 21, 2026. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Biogen Inc's 2026 meeting?
- The board is presenting 10 director nominees at the Biogen Inc 2026 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Biogen Inc 2026 meeting?
- Shareholders will vote on 3 proposals at the Biogen Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.